Stock INSD INSTADOSE PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Instadose Pharma Corp.

Equities

INSD

US45783B1035

Delayed OTC Markets
Other stock markets
 15:34:47 2023-12-29 EST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Instadose Pharma Corp. -.--% -.--%
2023 TetraPharma Royalty Corp. acquired TetraPharma Ltd. from Instadose Pharma Corp.. CI
2023 An unknown buyer entered into an agreement to acquire TetraPharma Ltd. from Instadose Pharma Corp. for $0.0001 million. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
INSTADOSE PHARMA CORP. : Non-Reliance on Previous Financials, Audits or Interim Review, Financial Statements and Exhibits (form 8-K)
AQ
INSTADOSE PHARMA CORP. : Financial Statements and Exhibits (form 8-K)
AQ
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
INSTADOSE PHARMA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
INSTADOSE PHARMA CORP. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
AQ
Investor Notice: Feb 28th Deadline for certain Investors in Instadose Pharma Corp. shares announced by Shareholders Foundation
PR
INSTADOSE PHARMA CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Instadose US Announces Management Transition
AQ
Instadose US Announces Management Transition
PR
INSTADOSE PHARMA CORP. : Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Other Events (form 8-K)
AQ
Instadose Pharma Corp Ships 2.125 Metric Tons - Largest International Cannabis Delivery in History
PR
North Macedonia a critical part of Instadose’s plans to become world’s largest medical cannabis supplier
AQ
INSTADOSE PHARMA CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
INSTADOSE PHARMA CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
Mikrocoze : INSTADOSE PHARMA CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INSTADOSE PHARMA CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
INSTADOSE PHARMA : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INSTADOSE PHARMA CORP. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
INSTADOSE PHARMA CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INSD Stock
  4. News Instadose Pharma Corp.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW